News you may have missed #828

By IAN ALLEN | intelNews.org |
Chinese researcher charged with stealing US drug. Chinese cancer researcher Huajun Zhao, 42, who has been working in the United States since 2006, has been charged with stealing data and an experimental compound from the Medical College of Wisconsin. The federal complaint accuses Zhao of stealing the compound, C-25, which could potentially assist in killing cancer cells without damaging normal cells. An FBI investigation turned up evidence that Zhao hoped to claim credit in China for discovering C-25. He had already claimed on a research website that he had discovered an unnamed compound he hoped to take to China.
Turkish intelligence to ‘oversee PKK retreat’. Turkey’s National Intelligence Agency, MİT, will oversee the withdrawal of Kurdistan Workers Party (PKK) militants, according to Turkey’s Deputy Prime Minister, Bülent Arınç. Last month, Abdullah Öcalan, the leader of the armed Kurdish group that has battled Turkey for 30 years, proclaimed an immediate ceasefire in PKK’s conflict with the Turkish state, which has claimed about 35,000 lives. Speaking on Turkey’s state-run broadcaster, TRT, Arınç said no legislation would be introduced to facilitate the withdrawal, but “certainly MİT will oversee it; security forces will take part in it, too”, he added.
Analysis: Controversial Bush programs continue under Obama. During the George W. Bush years, two of the most controversial elements of what was then called the Global War on Terrorism were the CIA’s rendition, detention and interrogation (RDI) program and the creation of the prison camps at Guantanamo Bay. Guantanamo Bay and the RDI program are both back in the news now, each for their own unsavory reasons. The Pentagon is requesting nearly $200 million for Guantanamo Bay infrastructure upgrades, including $49 million for a new unit for ‘special’ prisoners. Meanwhile, participation in the CIA’s controversial RDI program has resulted —for at least one person— not in prosecution or professional sanctions, but rather in a promotion.